Postmortem interval determination using mRNA markers and DNA normalization

Int J Legal Med. 2020 Jan;134(1):149-157. doi: 10.1007/s00414-019-02199-7. Epub 2019 Nov 26.

Abstract

Postmortem interval (PMI) determination is an important part of criminal investigations, but it is still subject to uncertainty. Degradation of mRNA in PMI determination has been studied in decays; however, some studies have reported no correlation between PMI and RNA degradation. Thus, we aimed to determine whether RNA quantity was correlated with PMI. Heart and brain tissues were separated from a mouse model of a 0-48 h PMI with 29 time points. We then coextracted the DNA and RNA in one tube with Bioteke coextraction kits and selected some mRNA markers associated with cell oxygen deprivation and apoptosis as target genes, such as hypoxia-associated factor (HAF), apoptosis-inducing factor (AIF), hypoxia-inducible factor 2 alpha (HIF2a), and factor inhibiting HIF (FIH). We measured the quantity of these markers using real-time quantitative PCR (qPCR), and Caspase-3 DNA and 18S were each used for normalization. The results showed that in the heart tissue, the degradation of HIF2a, AIF, and FIH was correlated with PMI, as was the degradation of HIF2a, FIH, and AIF in brain tissue when normalized with Caspase-3 DNA. However, when normalized with 18S, only the degradation of HIF2a in brain tissue was correlated with PMI. Interestingly, the quantity of HAF in brain tissue was found to increase after death with either 18S or Caspase-3 DNA normalization, and it was significantly correlated with 0-48 h PMI. These results indicated that mRNA quantity can be used to determine PMI and that Caspase-3 DNA is feasible for PMI estimation. In summary, we established mathematical models for PMI determination using multiple mRNA markers and multiple tissues and further studies are needed to validate and investigate these markers and mathematical models in human tissues.Duo Peng and Meili Lv contributed equally to this work.

Keywords: DNA and RNA coextraction; Degradation; PMI estimation; mRNA markers.

MeSH terms

  • Animals
  • Apoptosis Inducing Factor / genetics
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Biomarkers / analysis*
  • Brain / metabolism
  • Caspase 3 / genetics
  • DNA Primers
  • Mice
  • Mice, Inbred C57BL
  • Mixed Function Oxygenases / genetics
  • Models, Animal
  • Models, Theoretical
  • Myocardium / metabolism
  • Nucleic Acids / isolation & purification
  • Postmortem Changes*
  • RNA Stability*
  • RNA, Messenger / analysis*
  • RNA, Ribosomal, 18S / genetics
  • Real-Time Polymerase Chain Reaction
  • Ribonucleoproteins, Small Nuclear / genetics

Substances

  • Apoptosis Inducing Factor
  • Basic Helix-Loop-Helix Transcription Factors
  • Biomarkers
  • DNA Primers
  • Nucleic Acids
  • AIFM1 protein, mouse
  • RNA, Messenger
  • RNA, Ribosomal, 18S
  • Ribonucleoproteins, Small Nuclear
  • Sart1 protein, mouse
  • endothelial PAS domain-containing protein 1
  • Mixed Function Oxygenases
  • factor inhibiting hypoxia-inducible factor 1, mouse
  • Casp3 protein, mouse
  • Caspase 3